3Q23 & 9M23 Performance Overview

Thousands Private large portfolio companies EXTERNALLY VALUED + MEDICAL INSURANCE BUSINESS OVERVIEW (CONT'D) NUMBER OF INSURED & RENEWAL RATE 85.0% 83.6% 83.2% 74.3% 76.9% 77.5% 78.0% 77.4% 73.4% 73.4% 75.6% 69.7% +6.6% 234 236 +6.6% 211 174 155 157 165 164 160 171 171 160 96.7% 104.7% 102.5% 94.1% GEL million REVENUE (NET INSURANCE PREMIUMS EARNED) GEORGIA CAPITAL +23.7% 75.4 58.6 61.5 72.4 69.5 74.8 66.6 53.7 55.1 +21.2% 53.8 17.4 21.1 2015 2016 2017 2018 2019 2020 2021 2022 3Q22 3Q23 9M22 9M23 2015 2016 2017 2018 COMBINED RATIO 2019 2020 2021 2022 3Q22 3Q23 9M22 9M23 NET PROFIT 96.1% 90.6% 97.4% 99.5% 101.0% 94.6% 101.1% 95.5% -5.6 ppts -6.4 ppts 84.1% 78.7% 84.2% 77.3% 81.4% 73.0% 79.3% 81.0% 81.3% 77.6% 82.2% 79.7% 18.0% 20.6% 18.3% 16.8% 14.7% 2015 2016 2017 2018 2019 2020 17.6% 18.1% 18.5% 19.7% 17.0% 18.9% 15.8% 3Q22 3Q23 9M22 9M23 Georgia Capital PLC | General note: 3Q22 and 9M22 results have been retrospectively adjusted for IFRS 17 impact. 2021 2022 GEL million 4.4 2.9 1.8 6.4 +253.0% 3.8 3.4 1.5 1.1 0.3 +198.2% 4.3 2015 2016 2017 2018 2019 2020 2021 2022 3Q22 3Q23 9M22 9M23 (2.6) (4.9) 88

View entire presentation